NEUP: Koefisien rega marang pendapatan Neuphoria Therapeutics, Inc.

Tandha merek Neuphoria (NEUP)

The complexity of developing neuropreparations and stringent FDA oversight create significant barriers to entry. The ratio of company value to annual revenue demonstrates current valuation dynamics, where the indicator level stands at 11.50. Neuphoria Therapeutics Inc. (NEUP) is developing a non-addictive PTSD treatment based on BNC210, however, expanding the portfolio requires constant capital infusions due to high laboratory costs.

Kapitalisasi marang pendapatan: Neuphoria Therapeutics, Inc. (NEUP) kanggo 25.01.2025 - 17.11.2026

Rincian analitis perusahaan Neuphoria Therapeutics, Inc. (NEUP)

Analisis umum perusahaan:NEUP - Neuphoria Therapeutics Inc.
Produk merek Neuphoria Therapeutics

The P/S ratio reflects the relationship between the market capitalization of Neuphoria Therapeutics Inc. (NEUP) and its annual revenue, measuring the cost of each unit of sales. Analyzing the company's P/S ratio allows an investor to assess whether the asset is overbought relative to historical averages. The price action of this line helps identify entry points with a maximum margin of safety. For a biotech startup investing in a team of scientists treating anxiety disorders, this multiple serves as an indicator of market expectations for future commercial success.

Pesaing Neuphoria Therapeutics Inc.

BIIB (Biogen) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NBIX (Neurocrine Corp)|Regencell Bioscience - Rasio rega marang pendapatan|Axsome Therapeutics - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Rasio rega marang pendapatan|Rega marang dodolan Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - Multiplikator P/S|CPRX: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S DNLI|Koefisien rega marang pendapatan Harmony Biosciences|Biohaven Ltd - Kapitalisasi marang pendapatan|Multiplikator P/S Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Praxis Corp PRAX|AVXL: Multiplikator P/S|CBLL (ceribell.com) - Rasio rega marang pendapatan|PRTA (Prothena Corporation) - Multiplikator P/S|Kapitalisasi marang pendapatan alector.com (ALEC)|Rasio rega marang pendapatan Annexon, Inc. (ANNX)|OMER - Rega marang dodolan|Multiplikator P/S NGNE (Neurogene Inc)|AC Immune (ACIU) - Rega marang dodolan|Voyager Therapeutics Inc - Multiplikator P/S|Neumora (NMRA) - Kapitalisasi marang pendapatan|SCLX: Multiplikator P/S|TVGN - Koefisien rega marang pendapatan|ACOG (Alpha Cognition Inc) - Multiplikator P/S|Kapitalisasi marang pendapatan cogrx.com (CGTX)|Rasio rega marang pendapatan Inhibikase Therapeutics Inc (IKT)|Koefisien rega marang pendapatan Cassava Sciences|Multiplikator P/S ASRT (Assertio Holdings)|COYA - Kapitalisasi marang pendapatan|vistagen.com - Multiplikator P/S|OVID: Rasio rega marang pendapatan|Acumen Pharmaceuticals, Inc (ABOS) - Rasio rega marang pendapatan|CervoMed Inc - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Alterity Therapeutics Limited|clene.com (CLNN) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan PEPG (PepGen Inc)|Multiplikator P/S jupiterneurosciences.com (JUNS)|Rasio rega marang pendapatan Relmada Therapeutics, Inc. RLMD|ANVS: Rasio kapitalisasi marang pendapatan|Grace Tx - Multiplikator P/S|AIFF (Firefly Neuroscience Inc) - Rasio kapitalisasi marang pendapatan|KLTO: Multiplikator P/S|NeuroSense Therapeutics, Ltd. (NRSN) - Multiplikator P/S|Rasio rega marang pendapatan Reviva Pharmaceuticals, Inc.|Kapitalisasi marang pendapatan metaviatx.com (MTVA)|Multiplikator P/S NRXS|HSDT - Rega marang dodolan|Passage Bio, Inc. - Kapitalisasi marang pendapatan|NERV: Rasio kapitalisasi marang pendapatan|ATHA: Kapitalisasi marang pendapatan|Addex Therapeutics Ltd - Kapitalisasi marang volume dodolan|Alzamend Neuro, Inc. (ALZN) - Rasio rega marang pendapatan|CYCN (Cyclerion Therapeutics Inc.) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan PTIX|KTTA: Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Brainstorm Cell Therapeutics, Inc. BCLI|Rasio kapitalisasi pasar marang pendapatan CARA|chromocell.com - Multiplikator P/S|Rasio rega marang dodolan ELYM|ITCI: Multiplikator P/S|Rega marang dodolan Longboard Pharmaceuticals, Inc. (LBPH)|Rasio rega marang pendapatan Marinus Pharmaceuticals, Inc.|NKGN: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NRBO|SAGE: Rasio rega marang dodolan|Synaptogenix Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - Multiplikator P/S|Anew Medical (WENA) - Kapitalisasi marang pendapatan|CERE (Cerevel Corp) - Kapitalisasi marang pendapatan